Recursion PharmaceuticalsRXRX 
$6.912.22%24h
2.22%24h
Global rank6332
Market cap$1.44B
Change 7d6.97%
YTD Performance-28.62%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Recursion Pharmaceuticals (RXRX)
As of November 2024, Recursion Pharmaceuticals has a market cap of $1.44B. This makes Recursion Pharmaceuticals the world's 6332th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Recursion Pharmaceuticals from 2021 to 2024
-
Value:-
Market cap history of Recursion Pharmaceuticals from 2021 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $2.49B | 21.11% |
| 2023 | $2.05B | 27.89% |
| 2022 | $1.61B | -54.99% |
| 2021 | $3.57B | - |
RXRX Market Cap Today is $1.44B 2.22% - 9 Nov 2024
View largest stocks by market cap 
